The Board of Directors of Novogene Co., Ltd. has authorized a buyback plan on February 5, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
14.7 CNY | -0.27% | -4.30% | -37.02% |
04-12 | Novogene Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
02-27 | Novogene Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-37.02% | 842M | |
-13.90% | 8.58B | |
+63.16% | 4.12B | |
-3.34% | 2.48B | |
-9.81% | 2.44B | |
-43.01% | 2.29B | |
-4.82% | 2B | |
-18.74% | 1.53B | |
-40.24% | 1.21B | |
+9.42% | 1.12B |
- Stock Market
- Equities
- 688315 Stock
- News Novogene Co., Ltd.
- Novogene Co., Ltd. authorizes a Buyback Plan.